Pyrazine derivatives for optical imaging and therapy
US8628751B2 · kind B2 · utility
7Cited by
5References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2010 |
| Grant date | Jan 14, 2014 |
| Priority date | — |
| Expiry date | Aug 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D241/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds, including compositions, preparations and formulations, and methods of using and making such compounds. Compounds of the present invention include pyrazine derivatives having a pyrazine core and a plurality of substituents. In some embodiments, pyrazine derivatives of the invention are pyrazine core compounds having one or more electron donating groups and one or more electron withdrawing groups optionally functionalized to provide useful optical, biological, pharmacokinetic and/or physical properties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.